{"component": "definition", "props": {"groups": [{"snippet_links": [], "samples": [{"hash": "3nIuupsQ84O", "uri": "/contracts/3nIuupsQ84O#licensed-compound", "label": "License Agreement (Avadel Pharmaceuticals PLC)", "score": 36.8412055969, "published": true}, {"hash": "hlLObtcT6jo", "uri": "/contracts/hlLObtcT6jo#licensed-compound", "label": "Collaboration and License Agreement (Spruce Biosciences, Inc.)", "score": 36.2854194641, "published": true}, {"hash": "pBWDwphbuY", "uri": "/contracts/pBWDwphbuY#licensed-compound", "label": "Collaboration and License Agreement (Septerna, Inc.)", "score": 35.6084861755, "published": true}], "size": 13, "snippet": "means [***].", "hash": "42145ccc68badf480a8ed917c57dd5fc", "id": 1}, {"snippet_links": [{"key": "effective-upon", "type": "clause", "offset": [20, 34]}, {"key": "pursuant-to-the-terms", "type": "clause", "offset": [49, 70]}, {"key": "section-72", "type": "clause", "offset": [84, 95]}, {"key": "option-compound", "type": "definition", "offset": [112, 127]}], "samples": [{"hash": "eey3UE3QyYT", "uri": "/contracts/eey3UE3QyYT#licensed-compound", "label": "Collaboration, License and Option Agreement (Acceleron Pharma Inc)", "score": 28.8494186401, "published": true}, {"hash": "9EwxkBykMCK", "uri": "/contracts/9EwxkBykMCK#licensed-compound", "label": "Collaboration, License and Option Agreement (Acceleron Pharma Inc)", "score": 27.590007782, "published": true}, {"hash": "hMtuFQsfiR9", "uri": "/contracts/hMtuFQsfiR9#licensed-compound", "label": "Collaboration, License and Option Agreement (Acceleron Pharma Inc)", "score": 24.6796722412, "published": true}], "size": 8, "snippet": "means ActRIIA, and, effective upon the dates and pursuant to the terms set forth in Section 7.2, any applicable Option Compound.", "hash": "4235da8117c832316b12ba87ef32c1f7", "id": 2}, {"snippet_links": [{"key": "tak-385-licensed-compound", "type": "definition", "offset": [8, 33]}, {"key": "tak-448-licensed-compound", "type": "definition", "offset": [39, 64]}], "samples": [{"hash": "bN0uNdaaAoT", "uri": "/contracts/bN0uNdaaAoT#licensed-compound", "label": "License Agreement (Myovant Sciences Ltd.)", "score": 31.376455307, "published": true}, {"hash": "3KlHyQRcRop", "uri": "/contracts/3KlHyQRcRop#licensed-compound", "label": "License Agreement (Myovant Sciences Ltd.)", "score": 27.8145103455, "published": true}, {"hash": "7bxdPJmyvpH", "uri": "/contracts/7bxdPJmyvpH#licensed-compound", "label": "License Agreement (Myovant Sciences Ltd.)", "score": 27.8008213043, "published": true}], "size": 7, "snippet": "means a TAK-385 Licensed Compound or a TAK-448 Licensed Compound.", "hash": "88b4963a0bb851db66ccaab8b6d8aecf", "id": 3}, {"snippet_links": [], "samples": [{"hash": "gYJbPyUdxoJ", "uri": "/contracts/gYJbPyUdxoJ#licensed-compound", "label": "Exclusive Patent and Know How License Agreement", "score": 31.3408622742, "published": true}, {"hash": "4PMoBDqD0kD", "uri": "/contracts/4PMoBDqD0kD#licensed-compound", "label": "Exclusive Patent and Know How License Agreement (Cerecor Inc.)", "score": 26.4428482056, "published": true}, {"hash": "5LfpWNdQfWi", "uri": "/contracts/5LfpWNdQfWi#licensed-compound", "label": "Exclusive Patent and Know How License Agreement (Cerecor Inc.)", "score": 26.3223819733, "published": true}], "size": 7, "snippet": "means those compounds listed in Schedule 1.23, including salts, esters, metabolites, prodrugs, acid forms, base forms, steroisomers, racemates, tautomers, polymorphs, solvates, hydrates and crystalline forms thereof.", "hash": "a2a94cd8adddd5760df15f09ca702a57", "id": 4}, {"snippet_links": [], "samples": [{"hash": "8oeCnXIySge", "uri": "/contracts/8oeCnXIySge#licensed-compound", "label": "License Agreement (Radius Health, Inc.)", "score": 32.5920600891, "published": true}, {"hash": "bNy5Cn94vfq", "uri": "/contracts/bNy5Cn94vfq#licensed-compound", "label": "License Agreement (Radius Health, Inc.)", "score": 26.1854896545, "published": true}, {"hash": "gbgIrfUX13q", "uri": "/contracts/gbgIrfUX13q#licensed-compound", "label": "License Agreement (Radius Health, Inc.)", "score": 22.8507862091, "published": true}], "size": 6, "snippet": "means (i) BIM-44058 or (ii) any analog of BIM-44058.", "hash": "82662bfd1b43c8b39488380b6afcd4cc", "id": 5}, {"snippet_links": [], "samples": [{"hash": "jkjHcDXVWHa", "uri": "/contracts/jkjHcDXVWHa#licensed-compound", "label": "Exclusive Patent License Agreement", "score": 31.3408622742, "published": true}, {"hash": "inQ6XOhn4ar", "uri": "/contracts/inQ6XOhn4ar#licensed-compound", "label": "Exclusive Patent License Agreement (ARMO BioSciences, Inc.)", "score": 28.9917869568, "published": true}, {"hash": "9LnzpFaKjxj", "uri": "/contracts/9LnzpFaKjxj#licensed-compound", "label": "Exclusive Patent License Agreement (ARMO BioSciences, Inc.)", "score": 28.8904857635, "published": true}], "size": 6, "snippet": "means PEG-IL10.", "hash": "c041a79b0e4b980b0eaaae8f966d6c29", "id": 6}, {"snippet_links": [], "samples": [{"hash": "toyNMkJhal", "uri": "/contracts/toyNMkJhal#licensed-compound", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "8wkFXVcAmCH", "uri": "/contracts/8wkFXVcAmCH#licensed-compound", "label": "Development and Marketing Agreement", "score": 27.0520191193, "published": true}, {"hash": "h4IzP3EHexR", "uri": "/contracts/h4IzP3EHexR#licensed-compound", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 24.5646820068, "published": true}], "size": 6, "snippet": "has the meaning set forth in Section 1.89.", "hash": "00f72078cb3d224d505d1629b8076b5a", "id": 7}, {"snippet_links": [], "samples": [{"hash": "ftnKotuiDe1", "uri": "/contracts/ftnKotuiDe1#licensed-compound", "label": "License Agreement (Tracon Pharmaceuticals, Inc.)", "score": 28.126625061, "published": true}, {"hash": "36vbxy8ZQhK", "uri": "/contracts/36vbxy8ZQhK#licensed-compound", "label": "License and Option Agreement (Tracon Pharmaceuticals, Inc.)", "score": 27.8555774689, "published": true}, {"hash": "avmaHooe3SI", "uri": "https://ir.traconpharma.com/static-files/8f9efea4-f381-4d80-ab22-827eb51becc0", "label": "ir.traconpharma.com", "score": 9.9952087402, "published": false}], "size": 6, "snippet": "means any AR Mutant Compound or NIK Compound.", "hash": "90b4431eac2cc5bc50919d7085883271", "id": 8}, {"snippet_links": [{"key": "chemical-name", "type": "clause", "offset": [58, 71]}], "samples": [{"hash": "hxM8h4fUJVk", "uri": "/contracts/hxM8h4fUJVk#licensed-compound", "label": "Exclusive License Agreement (Atherogenics Inc)", "score": 18.0, "published": true}, {"hash": "75mr2ZowLeE", "uri": "/contracts/75mr2ZowLeE#licensed-compound", "label": "Exclusive License Agreement (Atherogenics Inc)", "score": 18.0, "published": true}, {"hash": "3HN83ksOQyx", "uri": "/contracts/3HN83ksOQyx#licensed-compound", "label": "Exclusive License Agreement (Atherogenics Inc)", "score": 18.0, "published": true}], "size": 6, "snippet": "means the soluble analog of probucol AGI-1067, having the chemical name butanedioic acid, mono[4-[[1-[3,5-bis (1,1-dimethyethyl)-4-hydroxyphenyl]thio]-1-[methylethylthio]-2,6-bis (1,1-dimethylethyl)-phenyl]ester, and any stereoisomers, salts, hydrates and/or crystalline forms thereof.", "hash": "c07c7050f33703af971d8797bbc8ce45", "id": 9}, {"snippet_links": [{"key": "form-of", "type": "definition", "offset": [123, 130]}], "samples": [{"hash": "jM2zHaBrfZv", "uri": "/contracts/jM2zHaBrfZv#licensed-compound", "label": "License Agreement (Akebia Therapeutics, Inc.)", "score": 30.5989055634, "published": true}, {"hash": "9DdwXQENak3", "uri": "/contracts/9DdwXQENak3#licensed-compound", "label": "License Agreement (Akebia Therapeutics, Inc.)", "score": 28.6002731323, "published": true}, {"hash": "hjygkLQ0TV4", "uri": "http://ir.akebia.com/static-files/98ce011e-c5a9-4965-b369-cf6dc18a1120", "label": "Note", "score": 14.1704311371, "published": false}], "size": 6, "snippet": "means vadadustat, formerly known as AKB-6548, and any salt or crystal form thereof. Licensed Compound includes any prodrug form of vadadustat.", "hash": "d845f094fb705fc63402f13a154d03db", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIabGljZW5zZWQtY29tcG91bmQjMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "Licensed Compound", "size": 868, "snippet": "means [***].", "id": "licensed-compound", "examples": ["Except with respect to Losses indemnified by a Party pursuant to Article 16 (Indemnification; Limited Liability; Insurance), all reasonable Out-of-Pocket costs of the Parties or their respective Affiliates related to the defense of claims that the Exploitation of the <strong>Licensed Compound</strong> or Licensed Products infringes, misappropriates or otherwise violates a Third Party\u2019s intellectual property rights (\u201cShared Defense Costs\u201d) will be shared by the Parties in accordance with Article 12 (Payments)."], "related": [["licensed-compounds", "Licensed Compounds", "<strong>Licensed Compounds</strong>"], ["collaboration-compound", "Collaboration Compound", "Collaboration Compound"], ["licensed-antibody", "Licensed Antibody", "Licensed Antibody"], ["licensed-product", "Licensed Product", "Licensed Product"], ["collaboration-product", "Collaboration Product", "Collaboration Product"]], "related_snippets": [], "updated": "2026-04-19T04:24:51+00:00"}, "json": true, "cursor": ""}}